{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T00:21:28Z","timestamp":1719706888408},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,29]]},"DOI":"10.7759\/cureus.63463","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T13:53:13Z","timestamp":1719669193000},"source":"Crossref","is-referenced-by-count":0,"title":["Thymoma-Associated Pleural Effusion Treated With Neoadjuvant Chemotherapy"],"prefix":"10.7759","author":[{"given":"Sreshta","family":"Paranji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aatif","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rathnamitreyee","family":"Vegunta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fanucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000294","article-title":"Approaching the patient with an anterior mediastinal mass: a guide for clinicians","volume":"9","author":"Carter BW","year":"2014","unstructured":"Carter BW, Marom EM, Detterbeck FC. Approaching the patient with an anterior mediastinal mass: a guide for clinicians. J Thorac Oncol. 2014, 9:S102-9. 10.1097\/JTO.0000000000000294","journal-title":"J Thorac Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13244-012-0201-0","article-title":"A diagnostic approach to the mediastinal masses","volume":"4","author":"Juanpere S","year":"2013","unstructured":"Juanpere S, Ca\u00f1ete N, Ortu\u00f1o P, Mart\u00ednez S, Sanchez G, Bernado L. A diagnostic approach to the mediastinal masses. Insights Imaging. 2013, 4:29-52. 10.1007\/s13244-012-0201-0","journal-title":"Insights Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/7622.4013","article-title":"A study of clinical characteristicsof mediastinal mass","volume":"8","author":"Aroor AR","year":"2014","unstructured":"Aroor AR, Prakasha S R, Seshadri S, S T, Raghuraj U. A study of clinical characteristicsof mediastinal mass. J Clin Diagn Res. 2014, 8:77-80. 10.7860\/JCDR\/2014\/7622.4013","journal-title":"J Clin Diagn Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1378\/chest.128.4.2893","article-title":"Tumors of the mediastinum","volume":"128","author":"Duwe BV","year":"2005","unstructured":"Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest. 2005, 128:2893-909. 10.1378\/chest.128.4.2893","journal-title":"Chest"},{"key":"ref5","article-title":"Anterior mediastinal mass","author":"Almeida PT","year":"2024","unstructured":"Almeida PT, Heller D. Anterior mediastinal mass. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2280","article-title":"Thymoma: state of the art","volume":"17","author":"Thomas CR","year":"1999","unstructured":"Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999, 17:2280-9. 10.1200\/JCO.1999.17.7.2280","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2003.07.042","article-title":"WHO histologic classification is a prognostic indicator in thymoma","volume":"77","author":"Kondo K","year":"2004","unstructured":"Kondo K, Yoshizawa K, Tsuyuguchi M, et al.. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004, 77:1183-8. 10.1016\/j.athoracsur.2003.07.042","journal-title":"Ann Thorac Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11606","article-title":"Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma","volume":"98","author":"Yoh K","year":"2003","unstructured":"Yoh K, Goto K, Ishii G, et al.. Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma. Cancer. 2003, 98:926-31. 10.1002\/cncr.11606","journal-title":"Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.12.048","article-title":"A meta-analysis of induction therapy for advanced thymic epithelial tumors","volume":"99","author":"Hamaji M","year":"2015","unstructured":"Hamaji M, Ali SO, Burt BM. A meta-analysis of induction therapy for advanced thymic epithelial tumors. Ann Thorac Surg. 2015, 99:1848-56. 10.1016\/j.athoracsur.2014.12.048","journal-title":"Ann Thorac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000024","article-title":"Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study","volume":"39","author":"Modh A","year":"2016","unstructured":"Modh A, Rimner A, Allen PK, et al.. Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic carcinoma: a retrospective multicenter study. Am J Clin Oncol. 2016, 39:120-5. 10.1097\/COC.0000000000000024","journal-title":"Am J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1993.01420200029005","article-title":"Thymectomy for myasthenia gravis","volume":"128","author":"Blossom GB","year":"1993","unstructured":"Blossom GB, Ernstoff RM, Howells GA, Bendick PJ, Glover JL. Thymectomy for myasthenia gravis. Arch Surg. 1993, 128:855-62. 10.1001\/archsurg.1993.01420200029005","journal-title":"Arch Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11655","article-title":"Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group","volume":"93","author":"Hirokawa M","year":"2008","unstructured":"Hirokawa M, Sawada K, Fujishima N, et al.. Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study group. Haematologica. 2008, 93:27-33. 10.3324\/haematol.11655","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga K","year":"1994","unstructured":"Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T, Shimosato Y. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int. 1994, 44:359-67. 10.1111\/j.1440-1827.1994.tb02936.x","journal-title":"Pathol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266407-thymoma-associated-pleural-effusion-treated-with-neoadjuvant-chemotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T13:53:17Z","timestamp":1719669197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266407-thymoma-associated-pleural-effusion-treated-with-neoadjuvant-chemotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,29]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.63463","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,29]]}}}